La bourse ferme dans 7 h 33 min

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
529,81+0,04 (+0,01 %)
À la clôture : 04:00PM EDT
503,32 -26,49 (-5,00 %)
Échanges après Bourse : 07:21PM EDT

IDEXX Laboratories, Inc.

One IDEXX Drive
Westbrook, ME 04092
United States
207 556 0300
https://www.idexx.com

Secteur(s)Healthcare
Secteur d’activitéDiagnostics & Research
Employés à temps plein11 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Jonathan J. MazelskyPresident, CEO & Director2,04M15,15M1961
Mr. Brian P. McKeonCFO, Executive VP & Treasurer1,06M258,69k1962
Mr. James F. PolewaczykExecutive VP & Chief Commercial Officer889,99kS.O.1964
Mr. Michael J. LaneExecutive VP and GM of Reference Laboratories & Information Technology891,1kS.O.1968
Dr. Nimrata Khatra Hunt P.E., Ph.D.Executive Vice President of Strategy, Sector Development & Global Operations887,77kS.O.1968
Mr. John HartSenior Vice President of Global OperationsS.O.S.O.S.O.
Mr. Jeffery D. ChadbourneSenior Vice President of Commercial Finance & Sales OperationsS.O.S.O.1976
Dr. Martin Smith Ph.D.Executive VP & CTOS.O.S.O.1968
Mr. Ken GradySenior VP & Chief Information OfficerS.O.S.O.S.O.
Ms. Sharon E. UnderbergExecutive VP, General Counsel, & Corporate Secretary881,05k84,31k1961
Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Gouvernance d’entreprise

L’ISS Governance QualityScore de IDEXX Laboratories, Inc. en date du 1 mars 2024 est 6. Les scores principaux sont Audit : 9; Société : 2; Droits des actionnaires : 9; Compensation : 2.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.